DRZID
STJ

DePrince Race & Zollo Inc (DRZ)’s St Jude Medical STJ Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-461,055
Closed -$37M – 281
2016
Q4 		$37M Sell
461,055
-6,006
-1% -$477K 0.72% 53
2016
Q3 		$37.3M Sell
467,061
-69,479
-13% -$5.61M 0.79% 43
2016
Q2 		$41.9M Sell
536,540
-893,424
-62% -$63.7M 0.85% 37
2016
Q1 		$78.6M Buy
+1,429,964
New +$77.9M 1.58% 2

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s STJ Position: Q1 2017 in Review

DePrince Race & Zollo Inc (DRZ) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 461,055 shares — an estimated $37M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in STJ in Q1 2016 and held it in 4 quarters. The position peaked at $78.6M in Q1 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 461,055 St Jude Medical shares in Q1 2017, an estimated $37M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in St Jude Medical in Q1 2016 and held it in 4 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s St Jude Medical position peaked at $78.6M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2017, filed 11 May 2017.